In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point
Who needs glutathione
Target: 200300 mcg daily by Weeks 512
By boosting glutathione levels, MaxGXL helps protect your cells from oxidative stress, supports your immune system, and enhances overall energy levels
To identify beneficiaries with peripheral arterial disease (PAD), we used ICD-9 diagnosis codes for PAD identified by either Hirsh et al (August 2008) or Jaff et al (July 2010) in their analyses of peripheral arterial disease among Medicare beneficiaries
Your clinician will also evaluate medications you're taking, any ongoing pelvic floor issues, and psychological factorspostpartum depression and anxiety affect medication tolerance and adherence